Novak Alfred J 4
4 · Pasithea Therapeutics Corp. · Filed Mar 1, 2024
Insider Transaction Report
Form 4
Novak Alfred J
Director
Transactions
- Award
Stock Option (right to buy)
2024-03-01+5,000→ 5,000 totalExercise: $8.34Exp: 2034-02-28→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The option award (the "Option") was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date.